Results 191 to 200 of about 3,028 (210)

MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH

Cell Metabolism, 2022
Gautm Bandyopadhyay, Wei Ying, Jerrold Olefsky   +2 more
exaly  

miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1

Journal of the Neurological Sciences, 2020
Baiping Wang
exaly  

miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β

Cell Research, 2010
Shuang Yang, Shen Wenwen
exaly  

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

British Journal of Cancer, 2011
Nijiro Nohata, Nakagawa M, Seki N
exaly  

miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

International Journal of Cancer, 2010
Hideki Enokida, Isamu Hoshino, Naohiko Seki   +2 more
exaly  

Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas

Journal of Cellular Biochemistry, 2006
Igor Pogribny, Tasneem Motiwala
exaly  

Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma

Cancer Epidemiology, 2012
Jörg Ellinger, Alexander Von Ruecker, Edwin Herrmann   +2 more
exaly  

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles

International Journal of Molecular Sciences, 2020
Maksim Sorokin, Rok Romih, Anton Buzdin   +2 more
exaly  

miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells

Cancer Letters, 2010
Michiko Matsuse, Shunichi Yamashita, Norisato Mitsutake   +2 more
exaly  

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

British Journal of Cancer, 2010
Nakagawa M, Seki N, Enokida H
exaly